Bioequivalence Studies of Two Formulations of Baclofen Tablet in Healthy Volunteers
Authors
Abstract
The relative bioavailability of the test (generic) product 2 × 25 mg baclofen tablets, with respect to the reference product, Lioresal® 2 × 25 mg tablets (baclofen; Squibb) was determined in a single- blind, single dose, randomised, crossover study. The mean values for the variable Cmax were 737.6 ng/ml for the reference and 739.5 ng/ml for the test product. The mean values for the variable AUC were 3980.3 hr.ng/ml and 4066.7 ng.hr/ml for the reference and test, respectively. The 90% confidence intervals for the “test/reference” mean ratios of the plasma baclofen pharmacokinetic variables Cmax and AUC0-t (as measures of the rate and extent of absorption of baclofen, respectively) lie between 0.98 and 1.06, which is within the conventional bioequivalence range of 80-125%. The test product (baclofen) is therefore bioequivalent to the reference product (Lioresal®) with respect to the rate and the extent of absorption of baclofen with a strength of 25 mg.
Highlights
Copyright
© 2022, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.
Similar Articles
Comparative Bioavailability of Ranitidine Tablets in Healthy Volunteers
Aboofazeli R, Shafaati A. Comparative Bioavailability of Ranitidine Tablets in Healthy Volunteers. Iran J Pharm Res. 2002;1(1):e129835. doi: https://doi.org/10.22037/ijpr.2010.2
Bioequivalence Comparison of Two Formulations of Fixed-Dose Combination Glimepiride/Metformin (2/500 mg)Tablets in Healthy Volunteers
Jung S, Chae J, Song B, Kwona K. Bioequivalence Comparison of Two Formulations of Fixed-Dose Combination Glimepiride/Metformin (2/500 mg)Tablets in Healthy Volunteers. Iran J Pharm Res. 2014;13(2):e125532. doi: https://doi.org/10.22037/ijpr.2014.1495
Pharmacokinetics and Bioequivalence of Two Formulations of Apixaban Tablets: A Double-Blind, Single-Dose, Crossover Study in Healthy Subjects
Abdollahizad E, Haeri A, Jouyban A, Afshar Mogaddam MR, Abbasian Z, et al. Pharmacokinetics and Bioequivalence of Two Formulations of Apixaban Tablets: A Double-Blind, Single-Dose, Crossover Study in Healthy Subjects. Iran J Pharm Res. 2025;24(1):e157714. doi: https://doi.org/10.5812/ijpr-157714
Comparative Bioavailability of Two Tablet Formulations of Dipyridamole in Healthy Volunteers
Beiki D, Amini M, Dowlatabadi R, Pirali M. Comparative Bioavailability of Two Tablet Formulations of Dipyridamole in Healthy Volunteers. Iran J Pharm Res. 2022;2(4):e127973. doi: https://doi.org/10.22037/ijpr.2010.58
Comparative in vitro and in vivo Bioequivalence Analysis of some Brands of film coated Atorvastatin (a BCS Class II Compound) tablets marketed in Nigeria
Okorie O, Paul Azubuike C, O. Ilomuanya M, Ubani-Ukoma U. Comparative in vitro and in vivo Bioequivalence Analysis of some Brands of film coated Atorvastatin (a BCS Class II Compound) tablets marketed in Nigeria. J Rep Pharm Sci. 2016;5(2):e147651. doi:
- Scopus by DOI: 5
Last Update: 3 weeks ago
- Scopus by Title: 5
Last Update: 3 weeks ago
- Scopus by Title (Ref): 0
Last Update: 3 weeks ago
- CrossRef: 0
Last Update: 6 days ago
- OpenAlex: 9
Last Update: 6 hours ago
- OpenCitations: 0
Last Update: 4 days ago